|
|||||
|
Issue 31 - Update on Pandemic Influenza: The Threat Moves Closer to Reality _______________________________________________________________________________ Update on Pandemic Influenza: The Threat Moves Closer to Reality Pandemic influenza is defined as the efficient and sustained transmission of a new influenza A virus which is spread by large droplets (coughing, sneezing). A new strain is usually caused by antigenic drift from animals to humans, i.e., when a human with influenza is also infected by a flu strain from an animal.(1) According to the World Health Organization, the latest avian flu virus, H5N1, has demonstrated several characteristics that increase the probability of a pandemic.(2) To start with, the H5N1 virus has shown evidence of becoming hardier and lasting longer in the environment. It is easily transmitted in wild ducks and geese, and can infect domestic poultry. In the domestic birds, the disease spreads efficiently and has a high morbidity rate. Since 2003, over 100 million chickens have died in Vietnam, Thailand, Laos, Cambodia, Indonesia, Malaysia, and China.(1) And recent evidence indicates that the virus now spreads from human to human.(3) So far, person to person spread has been limited to only one generation of human-to-human transmission.(1) Not all avian flu viruses spread to humans. When they do, most do not cause serious illness. Yet the H5N1 has spread from poultry to humans and caused serious disease with an extremely high fatality rate of 62%. As of April 14, 2005, there have been 17 cases, 12 deaths in Thailand; 68 cases, 36 deaths in Vietnam; and 3 cases, 3 deaths in Cambodia.(4) The course of the H5N1 disease in humans includes diarrhea in addition to influenza symptoms, along with severe ARDS. The only effective anti-viral treatment available is oseltamivir. A New Role for Syndromic Surveillance The Pandemic Influenza Preparedness and Response Plan, issued in draft form last August by the Department of Health and Human Services, notes that “efforts are under way to move toward year-round reporting.” It also notes that “Future enhancements will include exploring use of existing electronic datasets to increase the flexibility of the existing system to respond to emergencies, exploring hospital based surveillance for severe respiratory syndromes that may be caused by influenza but also may be related to SARS or other agents.” (5) This newsletter includes a case study, which shows how one state, with the participation of its major hospitals, has already implemented these enhancements. Case Study: How North Dakota Uses Syndromic Surveillance to Track Influenza Beginning in March of 2004, Goplin started using the in-place syndromic surveillance program for conducting influenza surveillance year-round. According to Goplin, "this is a major goal of the pandemic influenza plan, and our system allows us to meet this goal without expanding the traditional, physician-based sentinel system to a year-round system. And the syndromic system provides us with daily data instead of weekly data." She has also created a web site for making data available to the participating hospitals. The syndromic surveillance software program used by the NDDoH is the proprietary system, RedBat(r). It is used by ten hospitals in North Dakota, and covers seven of the largest cities and highest populated counties, including over 50 percent of the state's population. References (2) World Health Organization. Avian Influenza: Assessing the Pandemic Threat. January 2005. Available at (3) Ungchusak K, et al. Probable person-to-person transmission of avian influenza A (H5N1). New England Journal of Medicine. 2005 Jan 27:352(4):333-40. (4) World Health Organization.Cumulative Number of Confirmed Cases of Avian Influenza. Available at http://www.who.int/csr/disease/avian_influenza/country/cases_table_2005_04_14/en/ (5) U.S. Department of Health and Human Services. Draft: Pandemic Influenza Preparedness and Response Plan. August 2004. Available at Annual Syndromic Surveillance Conference Date Finalized
|
|||||
|
HOME | PRODUCTS
| RESOURCES | SUPPORT
| ABOUT US | CONTACT
US
Copyright © 2008 ICPA, Inc. All rights reserved. (800) 426-8015 ext. 224 sales@icpa.net 515 South Capital of Texas Highway, Suite 240 Austin, Texas 78746-4305 |
|||||
|
|
|||||